Natus Medical Incorporated is a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.
Company profile
Ticker
NTUS
Exchange
Website
CEO
Jonathan Kennedy
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Masimo • LivaNova • BioPlus Acquisition • GigCapital5 • Outset Medical • Fonar ...
SEC CIK
Corporate docs
Subsidiaries
Natus Manufacturing Limited • Natus Medical Denmark ApS • Excel-Tech Corp. ...
IRS number
770154833
NTUS stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
1 Aug 22
EFFECT
Notice of effectiveness
25 Jul 22
EFFECT
Notice of effectiveness
25 Jul 22
EFFECT
Notice of effectiveness
25 Jul 22
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Jul 22
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Jul 22
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Jul 22
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Jul 22
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Jul 22
POS AM
Prospectus update (post-effective amendment)
21 Jul 22
Transcripts
NTUS
Earnings call transcript
2021 Q4
25 Feb 22
NTUS
Earnings call transcript
2021 Q3
5 Nov 21
NTUS
Earnings call transcript
2021 Q2
8 Aug 21
NTUS
Earnings call transcript
2021 Q1
9 May 21
NTUS
Earnings call transcript
2020 Q4
28 Feb 21
NTUS
Earnings call transcript
2020 Q3
31 Oct 20
NTUS
Earnings call transcript
2020 Q2
2 Aug 20
NTUS
Earnings call transcript
2020 Q1
2 May 20
NTUS
Earnings call transcript
2019 Q4
6 Feb 20
NTUS
Earnings call transcript
2019 Q3
26 Oct 19
Latest ownership filings
4
ALICE D. SCHROEDER
21 Jul 22
4
BRYANT M MOORE
21 Jul 22
4
JOSHUA LEVINE
21 Jul 22
4
Lisa Wipperman Heine
21 Jul 22
4
Eric Guerin
21 Jul 22
4
Ilan Daskal
21 Jul 22
4
Thomas Joseph Sullivan
21 Jul 22
4
Benjamin Drew Davies
21 Jul 22
4
Austin Francis Noll III
21 Jul 22
4
DONG CHUNE CHRISTOPHER CHUNG
21 Jul 22
Financial summary
| Quarter (USD) | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Institutional ownership, Q4 2022
| 13F holders | Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 1 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 0.00 |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 Jul 22 | Dong Chune Christopher Chung | Common Stock, $0.001 par value per share | Sale back to company | Dispose D | No | No | 33.5 | 83,374 | 2.79 mm | 0 |
| 21 Jul 22 | Dong Chune Christopher Chung | Common Stock, $0.001 par value per share | Grant | Acquire A | No | No | 0 | 35,056 | 0.00 | 83,374 |
| 21 Jul 22 | Dong Chune Christopher Chung | Nonqualified Stock Option Common Stock | Sale back to company | Dispose D | No | No | 12.82 | 35,360 | 453.32 k | 0 |
| 21 Jul 22 | Austin Francis Noll III | Common Stock, $0.001 par value per share | Sale back to company | Dispose D | No | No | 33.5 | 200,509 | 6.72 mm | 0 |
| 21 Jul 22 | Austin Francis Noll III | Common Stock, $0.001 par value per share | Grant | Acquire A | No | No | 0 | 61,966 | 0.00 | 200,509 |
| 21 Jul 22 | Austin Francis Noll III | NQSO Common Stock | Sale back to company | Dispose D | No | No | 12.82 | 72,534 | 929.89 k | 0 |
| 21 Jul 22 | Benjamin Drew Davies | Common Stock, $0.001 par value per share | Sale back to company | Dispose D | No | No | 33.5 | 181,846 | 6.09 mm | 0 |
| 21 Jul 22 | Benjamin Drew Davies | Common Stock, $0.001 par value per share | Grant | Acquire A | No | No | 0 | 106,034 | 0.00 | 181,846 |
| 21 Jul 22 | Daskal Ilan | Common Stock, $0.001 par value per share | Sale back to company | Dispose D | No | No | 33.5 | 18,937 | 634.39 k | 0 |
| 21 Jul 22 | Sullivan Thomas Joseph | Common Stock, $0.001 par value per share | Sale back to company | Dispose D | No | No | 33.5 | 720,903 | 24.15 mm | 0 |